X0609 4 2026-06-22 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001209181 MOMTAZEE JAMES C false C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304 1 0 0 0 0 Common Stock 2026-06-22 4 A 0 3990 0 A 19070 D Common Stock 80000 I By The James Momtazee Revocable Trust Stock Option (Right to Buy) 68.92 2026-06-22 4 A 0 5277 0 A 2036-06-21 Common Stock 5277 5277 D Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The 80,000 shares reported herein as indirectly owned through the James C. Momtazee Revocable Trust (the "Trust") were previously reported as directly owned by the Reporting Person. The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. Exhibit 24 - Power of Attorney /s/ Will Solis, Attorney-in-Fact 2026-06-24